Precision NeuroMed's glioblastoma multiforme treatment granted FDA Orphan Drug Designation

Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio

Oxford Biomedica expands US operations with acquisition of viral vector facility in North Carolina

DarioHealth and OneStep partner to integrate fall risk technology into digital health platform

Ananda Pharma achieves key Phase 1 milestone for MRX1 CBD program

Alvotech and Advanz Pharma announce EMA acceptance of AVT23 marketing application

Polarean expands Ascend Imaging partnership to boost US market reach

Avobis Bio's AVB-114 implantable cell therapy granted US FDA RMAT designation for Crohn's perianal fistulas

Alto Neuroscience receives FDA Fast Track designation for ALTO-101

Calico Life Sciences' investigational treatment for ADPKD receives US FDA Fast Track Designation

Jazz Pharmaceuticals' Zepzelca (lurbinectedin) and atezolizumab (Tecentriq) combination approved by FDA in ES-SCLC

Hologic receives FDA clearance and CE mark for new gastrointestinal bacterial assays

Celltrion launches AVTOZMA IV in the United States following FDA approval

Vanda Pharmaceuticals agrees collaborative framework to resolve US FDA disputes

Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance